← Research library

Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides.

Animal research · 2020

What was studied
The available record identifies the subject in the title but gives no verified sample details.
Main finding
The later platform paper studies suppressive cyclic derivatives. Opposing experimental effects do not establish a shared receptor or clinical interchangeability.

Study data at a glance

Participants or experimental model
See original report; human, animal and laboratory components must be distinguished.
Reported results
The later platform paper studies suppressive cyclic derivatives. Opposing experimental effects do not establish a shared receptor or clinical interchangeability.
Study limitations and source details

Study limitations

  • The abstract leaves the preparation and study methods unclear.
  • Related publications may share experiments; source count is not independent-study count.

Source details

Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.

Sources checked

Citation

Animal / experimentalEnglish abstract

Deigin V, Ksenofontova O, Yatskin O, Goryacheva A, Ignatova A, Feofanov A, Ivanov V.. Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides. International immunopharmacology

Study source ↗ · DOI 10.1016/j.intimp.2020.106185 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards